Fulgent Genetics, Inc. FLGT Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s payments for repurchase of common stock?
- Fulgent Genetics, Inc. (FLGT) reported payments for repurchase of common stock of $40.08M in Q1 2026.
- How has Fulgent Genetics, Inc.'s payments for repurchase of common stock changed year-over-year?
- Fulgent Genetics, Inc.'s payments for repurchase of common stock increased by 361.8% year-over-year, from $8.68M to $40.08M.